Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter
Board of Directors continues its review of strategic alternatives to determine the Company’s optimal path forward
Read MoreBoard of Directors continues its review of strategic alternatives to determine the Company’s optimal path forward
Read MoreSignals continued investment in accelerated cardiovascular technology development
Read Morethe first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure
Read MoreCo-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessment
Read MoreDevice Intended to Reduce Risk of IV Catheter Failure and Replacement in Hospitals; Sister Product Orchid SRV-Type D for Drainage to Launch Simultaneously
Read MorePulse Technologies’ HSR™ electrode surface treatment is now part of Cardionomic’s Cardiac Pulmonary Nerve Stimulation (CPNS) System for treating heart failure.
Read MoreThe Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent
Read Moreto bring its intravascular device to market
Read MoreIt combines the advantages of the bare metal stent and drug-eluting stent, with nearly 600 grooves evenly cut in the hair-thin but extremely hard CoCr alloy
Read Moreto meet the needs for interventional treatment in different scenarios
Read More